Belsomra Tablets 10mg 100tab.
144 $
Find the best price
Dosage form
Belsomra is available as film-coated tablets in the following dosages:
- 5 mg
- 10 mg
- 15 mg
- 20 mg
Please note that the appearance of the packaging may vary depending on the manufacturer and region of sale.
Active ingredient
Suvorexant
Dosage
- Initial dose: The recommended initial dose is 10 mg taken 30 minutes before bedtime. After taking it there should be at least 7 hours before the time of awakening.
- Maximum dose: If necessary, the dose can be increased to 20 mg per day, depending on tolerability and efficacy. The tablets are taken once daily and eating may delay the onset of action of the drug.
Before using Belsomra, consultation with a physician is recommended to select an appropriate dosage and to take into account contraindications or possible interactions with other drugs.
Belsomra
Belsomra (active ingredient: suvorexant) is a medication indicated for the treatment of insomnia, specifically in patients experiencing difficulty falling asleep and/or maintaining sleep.
Indications for Use:
- Treatment of insomnia in adult patients.
Contraindications:
- Severe hepatic impairment.
- Narcolepsy or cataplexy.
- Concurrent use with strong CYP3A enzyme inhibitors.
- Concurrent use with other medications for the treatment of insomnia.
- Pregnancy and lactation periods (unless explicitly prescribed by a healthcare provider).
- Pediatric patients under 18 years of age.
- Hypersensitivity to suvorexant or any of the medication's components.
Side Effects:
- Headache.
- Drowsiness.
- Dizziness.
- Diarrhea.
- Xerostomia (dry mouth).
- Vivid or unusual dreams.
Important Information:
Before initiating treatment with Belsomra, consult a healthcare professional to determine the appropriate dosage and evaluate potential risks.
